Personality and Cancer Care Study
1 de marzo de 2021 actualizado por: Laura Perry, Tulane University
Personality and Cancer Care Study: Examining the Effects of a Personality Feedback Intervention in Adults With Cancer
This randomized clinical trial will test whether giving an individualized personality feedback report to adults with a history of cancer can improve their self-awareness, confidence in managing their illness, and mood.
Descripción general del estudio
Estado
Terminado
Condiciones
Intervención / Tratamiento
Descripción detallada
This will be a randomized clinical trial examining whether a personality feedback intervention can improve three outcomes in an online sample of adults with cancer: 1) self-awareness, 2) self-efficacy for managing aspects of their illness, and 3) mood.
The study will occur in a single 30-minute online session conducted in Qualtrics, with a pre-post randomized design.
Participants will respond to a baseline survey including a measurement of the Five-Factor Personality Model and measures of the 3 outcomes of interest, followed by random assignment to either an intervention group or control group.
Both groups will read a brief description of the Five-Factor Model of Personality.
Those randomized to the intervention group will also receive an individualized feedback report containing their personality results on each of the five personality factors and recommendations for cancer self-management based on these results.
After reading the personality information, participants will respond to the outcome measures again in a post-intervention survey.
Control participants will receive their individualized personality feedback reports after the study is complete.
Tipo de estudio
Intervencionista
Inscripción (Actual)
419
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Ubicaciones de estudio
-
-
Louisiana
-
New Orleans, Louisiana, Estados Unidos, 70118
- Tulane University
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
18 años y mayores (Adulto, Adulto Mayor)
Acepta Voluntarios Saludables
No
Géneros elegibles para el estudio
Todos
Descripción
Inclusion Criteria:
- consent to participate
- at least 18 years old (self-reported)
- have a current or past cancer diagnosis (self-reported)
Exclusion Criteria:
- under 18 years old (self-reported)
- indicate that they have no known history of cancer (self-reported)
- unable to read or understand English
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Cuidados de apoyo
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Personality Feedback
The intervention arm will read about the Five-Factor model and receive a feedback report with individualized personality results and self-management recommendations.
|
The intervention is a personality feedback report that will tell participants whether they scored low (bottom third), average (middle third), or high (top third) on each of the five factor personality characteristics based on gender-matched norms.
In addition to a description of general tendencies based on their level of each personality trait, the feedback will include information about how scoring in a given category may relate to an individual's cancer self-management or healthcare decision making.
The feedback for each personality trait will include recommendations for how to improve key outcomes.
|
|
Sin intervención: No-feedback Control
The control arm will read about the Five-Factor model but will not receive feedback or their personality results until after the study.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Self-Awareness Outcomes Questionnaire - Change Score
Periodo de tiempo: pre-intervention and immediately post-intervention.
|
Participants' current state-level self-awareness will be assessed with a modified 6-item short form of the Reflective Self-Development subscale included in the Self-Awareness Outcomes Questionnaire (SAOQ).
Participants rate each item from 1 to 5, and a total score will be calculated by summing participants responses to each item.
The total score at each time point will range from 6 to 30, with higher scores indicating higher levels of self-awareness.
The difference score from pre-intervention to post-intervention will be used in analyses, with higher scores indicating a greater increase in self-awareness.
|
pre-intervention and immediately post-intervention.
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
PROMIS Self-Efficacy for Managing Chronic Conditions - Change Score
Periodo de tiempo: pre-intervention and immediately post-intervention.
|
Participants will respond to three 4-item custom short forms from the Patient-Reported Outcomes Measurement Information System (PROMIS) Self-efficacy for Managing Chronic Conditions Domain: 1) self-efficacy for managing emotions, 2) self-efficacy for managing symptoms, and 3) self-efficacy for managing medications and treatment.
Each item is rated from 1 to 5, with raw scores on a summated total scale for each subscale ranging from 4 to 20.
Each subscale's raw total score will be converted to a T-score, and a mean composite T-score across the 3 subscales will be calculated for each time point.
Higher scores indicate higher levels of self-efficacy for managing their illness.
For analyses, the difference in the mean T-score from pre-intervention to post-intervention will be computed, with higher scores indicating a greater increase in self-efficacy for managing their illness.
|
pre-intervention and immediately post-intervention.
|
|
PANAS Positive Affect Subscale - Change Score
Periodo de tiempo: pre-intervention and immediately post-intervention.
|
The 10-item positive affect scale from the Positive and Negative Affect Schedule (PANAS) will be used to assess current mood.
Participants rate each item from 1 to 5, and a total summated scale score will range from 10 to 50, with higher scores indicating higher levels of positive affect.
For analyses, the difference score from pre-intervention to post-intervention will be calculated, with higher scores indicating a greater increase in positive mood.
|
pre-intervention and immediately post-intervention.
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Investigadores
- Investigador principal: Laura M Perry, MS, Tulane University
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Actual)
18 de noviembre de 2020
Finalización primaria (Actual)
8 de febrero de 2021
Finalización del estudio (Actual)
8 de febrero de 2021
Fechas de registro del estudio
Enviado por primera vez
3 de noviembre de 2020
Primero enviado que cumplió con los criterios de control de calidad
10 de noviembre de 2020
Publicado por primera vez (Actual)
12 de noviembre de 2020
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
2 de marzo de 2021
Última actualización enviada que cumplió con los criterios de control de calidad
1 de marzo de 2021
Última verificación
1 de marzo de 2021
Más información
Términos relacionados con este estudio
Otros números de identificación del estudio
- 2020-909
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
producto fabricado y exportado desde los EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .